GABA in the striatonigral and striatopallidal systems as moderator and mediator of striatal functions.
D000818:Animals; D014150:Antipsychotic Agents / Q000009:adverse effects; D001480:Basal Ganglia Diseases / Q000139:chemically induced; D002375:Catalepsy / Q000139:chemically induced; D003342:Corpus Striatum / Q000502:physiology*; D004027:Diencephalon / Q000502:physiology; D005917:Globus Pallidus / Q000502:physiology; D006801:Humans; D006816:Huntington Disease / Q000503:physiopathology; D009043:Motor Activity / Q000502:physiology*; D009069:Movement Disorders / Q000139:chemically induced; D009714:Nucleus Accumbens / Q000502:physiology; D010300:Parkinson Disease / Q000503:physiopathology; D051381:Rats; D013378:Substantia Nigra / Q000502:physiology*; D005680:gamma-Aminobutyric Acid / Q000502:physiology*
D014150:Antipsychotic Agents; D005680:gamma-Aminobutyric Acid